These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3572799)

  • 1. Comparative in vitro electrophysiology of quinidine, its major metabolites and dihydroquinidine.
    Thompson KA; Blair IA; Woosley RL; Roden DM
    J Pharmacol Exp Ther; 1987 Apr; 241(1):84-90. PubMed ID: 3572799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency-dependent interactions of mexiletine and quinidine on depolarization and repolarization in canine Purkinje fibers.
    Roden DM; Iansmith DH; Woosley RL
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1218-24. PubMed ID: 2447269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative electrophysiologic effects of metabolites of quinidine and hydroquinidine.
    Fautrez VM; Adamantidis MM; Caron JF; Libersa CC; Dupuis BA
    J Cardiovasc Pharmacol; 1992 Mar; 19(3):308-18. PubMed ID: 1378107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of quinidine on the transmembrane potentials of young and adult canine cardiac Purkinje fibers.
    Morikawa Y; Rosen MR
    J Pharmacol Exp Ther; 1986 Mar; 236(3):832-7. PubMed ID: 3950873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between use-dependent effects of antiarrhythmic drugs on conduction and Vmax in canine cardiac Purkinje fibers.
    Nattel S
    J Pharmacol Exp Ther; 1987 Apr; 241(1):282-8. PubMed ID: 3572790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiologic effects of halothane and quinidine on canine Purkinje fibers: evidence for a synergistic interaction.
    Gallagher JD; Gessman LJ; Moura P; Kerns D
    Anesthesiology; 1986 Sep; 65(3):278-85. PubMed ID: 3752573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Action potential prolongation and induction of abnormal automaticity by low quinidine concentrations in canine Purkinje fibers. Relationship to potassium and cycle length.
    Roden DM; Hoffman BF
    Circ Res; 1985 Jun; 56(6):857-67. PubMed ID: 4006095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative electrophysiological potencies of quinidine, 3-OH quinidine and quinidine-N-oxide in guinea-pig heart.
    Uematsu T; Sato R; Vozeh S; Follath F; Nakashima M
    Arch Int Pharmacodyn Ther; 1989; 297():29-38. PubMed ID: 2730239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course of the electrophysiological effects of quinidine on canine cardiac Purkinje fibers: concentration dependence and comparison with lidocaine and disopyramide.
    Nattel S; Bailey JC
    J Pharmacol Exp Ther; 1983 Apr; 225(1):176-80. PubMed ID: 6834270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency-dependent effects of antiarrhythmic drugs on action potential duration and refractoriness of canine cardiac Purkinje fibers.
    Nattel S; Zeng FD
    J Pharmacol Exp Ther; 1984 Apr; 229(1):283-91. PubMed ID: 6707943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent inhibition of yeast-expressed CYP2D6 by dihydroquinidine, quinidine, and its metabolites.
    Ching MS; Blake CL; Ghabrial H; Ellis SW; Lennard MS; Tucker GT; Smallwood RA
    Biochem Pharmacol; 1995 Sep; 50(6):833-7. PubMed ID: 7575645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmic activity of two quinidine metabolites in experimental reperfusion arrhythmia: relative potency and pharmacodynamic interaction with the parent drug.
    Vozeh S; Oti-Amoako K; Uematsu T; Follath F
    J Pharmacol Exp Ther; 1987 Oct; 243(1):297-301. PubMed ID: 3668860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency-dependent actions of phenytoin in adult and young canine Purkinje fibers.
    Spinelli W; Rosen MR
    J Pharmacol Exp Ther; 1986 Sep; 238(3):794-801. PubMed ID: 3746664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular electrophysiological effect of terikalant in the dog heart.
    Biliczki P; Acsai K; Virág L; Tálosi L; Jost N; Biliczki A; Papp JG; Varró A
    Eur J Pharmacol; 2005 Mar; 510(3):161-6. PubMed ID: 15763239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features and basic mechanisms of quinidine-induced arrhythmias.
    Roden DM; Thompson KA; Hoffman BF; Woosley RL
    J Am Coll Cardiol; 1986 Jul; 8(1 Suppl A):73A-78A. PubMed ID: 2423573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo and in vitro antiarrhythmic and arrhythmogenic effects of N-acetyl procainamide.
    Dangman KH; Hoffman BF
    J Pharmacol Exp Ther; 1981 Jun; 217(3):851-62. PubMed ID: 6164783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative electropharmacology of mexiletine, lidocaine and quinidine in a canine Purkinje fiber model.
    Burke GH; Loukides JE; Berman ND
    J Pharmacol Exp Ther; 1986 Apr; 237(1):232-6. PubMed ID: 3958966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition kinetics of dihydroquinidine following quinidine administration.
    Ueda CT; Williamson BJ; Dzindzio BS
    Res Commun Chem Pathol Pharmacol; 1976 Jun; 14(2):215-25. PubMed ID: 940955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma concentrations of quinidine, its major metabolites, and dihydroquinidine in patients with torsades de pointes.
    Thompson KA; Murray JJ; Blair IA; Woosley RL; Roden DM
    Clin Pharmacol Ther; 1988 Jun; 43(6):636-42. PubMed ID: 3378385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.